NDC 68462-409
propafenone hydrochloride 325 mg capsule, extended release
On the label: Glenmark Pharmaceuticals Inc., USA.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Recalls
- Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lot # 17230819, exp. date Mar-25 - Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lot # 17230767, exp. date Mar-25
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Propafenone: every company that makes it
- Form
- capsule, extended release, oral
- Strength
- 325 mg
- Approval
- ANDA ANDA205268
- On the market since
- Sep 8, 2017
- Package NDCs
68462-409-60- Official label
- DailyMed (National Library of Medicine), updated Jan 29, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?